RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+4.29%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$6.63B
AUM Growth
+$6.63B
(+0.06%)
Cap. Flow
+$484M
Cap. Flow
% of AUM
7.3%
Top 10 Holdings %
Top 10 Hldgs %
41.1%
Holding
130
New
17
Increased
26
Reduced
9
Closed
10
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
$238M |
| 2 |
Penumbra
PEN
|
$103M |
| 3 |
Tenaya Therapeutics
TNYA
|
$48.6M |
| 4 |
argenx
ARGX
|
$32.8M |
| 5 |
MacroGenics
MGNX
|
$29.9M |
Top Sells
| 1 |
QuidelOrtho
QDEL
|
$113M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$52.8M |
| 3 |
Protagonist Therapeutics
PTGX
|
$31.1M |
| 4 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$20.3M |
| 5 |
MiMedx Group
MDXG
|
$14.6M |
Sector Composition
| 1 | Healthcare | 91.48% |
| 2 | Financials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
IDEAYA Biosciences
IDYA
$2.26B
| $83.3M | 1.26% |
3,266,255
| – | – |
|
|
27
MacroGenics
MGNX
$121M
| $83.2M | 1.26% |
3,975,554
+1,428,629
| +56% | +$29.9M |
|
|
RXDX
28
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $77.4M | 1.17% |
3,264,031
| – | – |
|
29
Regenxbio
RGNX
$498M
| $77.4M | 1.17% |
1,845,366
+87,623
| +5% | +$3.67M |
|
30
Cytokinetics
CYTK
$5.98B
| $71.5M | 1.08% |
2,000,000
| – | – |
|
|
ITOS
31
DELISTED
iTeos Therapeutics
ITOS
| $63.5M | 0.96% |
2,353,015
+636,430
| +37% | +$17.2M |
|
|
LABP
32
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
| $62.4M | 0.94% |
427,572
| – | – |
|
|
CUTR
33
DELISTED
Cutera, Inc.
CUTR
| $58.6M | 0.88% |
1,257,862
+537,045
| +75% | +$25M |
|
|
AVDL
34
Avadel Pharmaceuticals
AVDL
$1.45B
| $56.3M | 0.85% |
5,741,939
| – | – |
|
35
ProQR Therapeutics
PRQR
$256M
| $53.9M | 0.81% |
6,443,113
| – | – |
|
36
Axsome Therapeutics
AXSM
$6.09B
| $53.3M | 0.8% |
1,616,497
| – | – |
|
|
37
Tenaya Therapeutics
TNYA
$192M
| $48.6M | 0.73% |
+2,458,750
| New | +$48.6M |
|
|
AGEN
38
Agenus
AGEN
$136M
| $47.6M | 0.72% |
462,343
-120,384
| -21% | -$12.4M |
|
39
Apyx Medical
APYX
$71.9M
| $47.1M | 0.71% |
3,398,279
+7,000
| +0.2% | +$97K |
|
40
Immunocore
IMCR
$1.78B
| $46.2M | 0.7% |
1,245,532
| – | – |
|
41
GH Research
GHRS
$870M
| $45.7M | 0.69% |
2,168,957
| – | – |
|
42
Outset Medical
OM
$245M
| $44.2M | 0.67% |
59,643
+10,500
| +21% | +$7.79M |
|
43
Tarsus Pharmaceuticals
TARS
$2.44B
| $43.4M | 0.65% |
2,013,601
| – | – |
|
|
44
argenx
ARGX
$44.2B
| $42.4M | 0.64% |
140,311
+108,559
| +342% | +$32.8M |
|
45
Pulmonx
LUNG
$67.6M
| $41.9M | 0.63% |
1,164,600
+35,000
| +3% | +$1.26M |
|
46
Relmada Therapeutics
RLMD
$48.8M
| $40.3M | 0.61% |
1,538,026
| – | – |
|
47
Castle Biosciences
CSTL
$673M
| $39.8M | 0.6% |
599,009
-200,000
| -25% | -$13.3M |
|
|
NSTG
48
DELISTED
NanoString Technologies, Inc.
NSTG
| $38.6M | 0.58% |
804,029
| – | – |
|
|
OLK
49
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $32M | 0.48% |
1,318,188
+70,000
| +6% | +$1.7M |
|
|
50
Protagonist Therapeutics
PTGX
$3.62B
| $31.1M | 0.47% |
1,753,695
-1,753,695
| -50% | -$31.1M |
|